Xencor (XNCR) Enterprise Value (2013 - 2026)
Xencor (XNCR) posted quarterly Enterprise Value of -$384.4 million for Q1 2026, down 334.1% year-over-year from $164.2 million in Q1 2025, and up 11.68% quarter-over-quarter from -$435.2 million in Q4 2025.
Analysis
Xencor (XNCR) Enterprise Value (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Enterprise Value for 14 consecutive years, with -$384.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 334.1% year-over-year to -$384.4 million; the TTM figure through Mar 2026 stood at -$384.4 million (down 334.1% YoY), while the FY2025 annual figure was -$435.2 million, up 4.01% from the prior year.
- Enterprise Value advanced to -$384.4 million in Q1 2026 per XNCR's latest filing, from -$435.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$60.8 million in Q2 2024 and bottomed at -$551.2 million in Q4 2023.
- Historically, Enterprise Value has averaged -$238.5 million across 5 years, with a median of -$112.1 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 79.54% — and 2025, when it slumped 563.28%.
- Xencor's Enterprise Value stood at -$96.4 million in 2022, then sank by 471.92% to -$551.2 million in 2023, then climbed by 17.73% to -$453.4 million in 2024, then gained by 4.01% to -$435.2 million in 2025, then rose by 11.68% to -$384.4 million in 2026.
- Business Quant data shows XNCR's Enterprise Value at -$384.4 million in Q1 2026, -$435.2 million in Q4 2025, and -$112.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 818.88 Mn |
| Mar 31, 2026 | 508.83 Mn |
| Dec 31, 2025 | 665.13 Mn |
| Sep 30, 2025 | 450.07 Mn |
| Jun 30, 2025 | 156.97 Mn |
| Mar 31, 2025 | 336.19 Mn |
| Dec 31, 2024 | 1.16 Bn |
| Sep 30, 2024 | 939.95 Mn |
| Jun 30, 2024 | 687.31 Mn |
| Mar 31, 2024 | 872.24 Mn |
| Dec 31, 2023 | 743.81 Mn |
| Sep 30, 2023 | 756.86 Mn |
| Jun 30, 2023 | 1.00 Bn |
| Mar 31, 2023 | 1.14 Bn |
| Dec 31, 2022 | 981.71 Mn |
| Sep 30, 2022 | 984.86 Mn |
| Jun 30, 2022 | 1.15 Bn |
| Mar 31, 2022 | 1.23 Bn |
| Dec 31, 2021 | 2.08 Bn |
| Sep 30, 2021 | 1.67 Bn |